{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["11(5)"],"submitter":["Ikeda M"],"pubmed_abstract":["Introduction
With the advent of effective systemic therapy, transarterial chemoembolization (TACE) is established as a highly effective locoregional treatment modality for carefully selected patients with hepatocellular carcinoma (HCC). This randomized controlled trial was conducted to clarify whether selective TACE with drug-eluting beads (DEB-TACE) loaded with epirubicin or selective conventional TACE (cTACE) with epirubicin-ethiodized oil might be more effective for obtaining complete response(CR) in patients with HCC.Methods
Between March 2016 and May 2019, Child-Pugh class A or B patients with unresectable HCC who were scheduled to receive selective TACE were randomly assigned at a 1:1 ratio to the DEB-TACE arm or the cTACE arm. The primary endpoint was the CR rate at "],"journal":["Liver cancer"],"pagination":["440-450"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9485929"],"repository":["biostudies-literature"],"pubmed_title":["Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302."],"pmcid":["PMC9485929"],"pubmed_authors":["Sugawara S","Tsukahara Y","Tsurusaki M","Kobayashi T","Azama K","Arai Y","Morita S","Sugihara E","Sone M","Kamimura K","Inaba Y","Kodama Y","Ikeda M","Tanaka T","Sato M","Anai H","Seki H","Aramaki T","Miyazaki M"],"additional_accession":[]},"is_claimable":false,"name":"Conventional or Drug-Eluting Beads? Randomized Controlled Study of Chemoembolization for Hepatocellular Carcinoma: JIVROSG-1302.","description":"Introduction
With the advent of effective systemic therapy, transarterial chemoembolization (TACE) is established as a highly effective locoregional treatment modality for carefully selected patients with hepatocellular carcinoma (HCC). This randomized controlled trial was conducted to clarify whether selective TACE with drug-eluting beads (DEB-TACE) loaded with epirubicin or selective conventional TACE (cTACE) with epirubicin-ethiodized oil might be more effective for obtaining complete response(CR) in patients with HCC.Methods
Between March 2016 and May 2019, Child-Pugh class A or B patients with unresectable HCC who were scheduled to receive selective TACE were randomly assigned at a 1:1 ratio to the DEB-TACE arm or the cTACE arm. The primary endpoint was the CR rate at ","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Sep","modification":"2025-04-04T21:34:59.062Z","creation":"2025-04-04T21:34:59.062Z"},"accession":"S-EPMC9485929","cross_references":{"pubmed":["36158586"],"doi":["10.1159/000525500"]}}